Back to Search
Start Over
Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2
- Source :
- Journal of Biological Chemistry, Journal of Biological Chemistry, 2010, 285 (11), pp.8422-8433. ⟨10.1074/jbc.M109.089128⟩, Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2010, 285 (11), pp.8422-8433. ⟨10.1074/jbc.M109.089128⟩
- Publication Year :
- 2010
- Publisher :
- HAL CCSD, 2010.
-
Abstract
- International audience; We report the first crystal structure of a 1:2 hormone.receptor complex that involves prolactin (PRL) as the ligand, at 3.8-A resolution. Stable ternary complexes were obtained by generating affinity-matured PRL variants harboring an N-terminal tail from ovine placental lactogen, a closely related PRL receptor (PRLR) ligand. This structure allows one to draw up an exhaustive inventory of the residues involved at the PRL.PRLR site 2 interface, consistent with all previously reported site-directed mutagenesis data. We propose, with this description, an interaction model involving three structural components of PRL site 2 ("three-pin plug"): the conserved glycine 129 of helix alpha3, the hydrogen bond network involving surrounding residues (glycine cavity), and the N terminus. The model provides a molecular basis for the properties of the different PRL analogs designed to date, including PRLR antagonists. Finally, comparison of our 1:2 PRL.PRLR(2) structure with those of free PRL and its 1:1 complex indicates that the structure of PRL undergoes significant changes when binding the first, but not the second receptor. This suggests that the second PRLR moiety adapts to the 1:1 complex rather than the opposite. In conclusion, this structure will be a useful guiding tool for further investigations of the molecular mechanisms involved in PRLR dimerization and activation, as well as for the optimization of PRLR antagonists, an emerging class of compounds with high therapeutic potential against breast and prostate cancer.
- Subjects :
- [SDV]Life Sciences [q-bio]
MESH: Protein Structure, Secondary
Ligand Binding Protein
MESH: Amino Acid Sequence
MESH: Drug Design
Biochemistry
Protein Structure, Secondary
MESH: Recombinant Proteins
MESH: Protein Structure, Tertiary
0302 clinical medicine
Protein structure
MESH: Structure-Activity Relationship
X-Ray Diffraction
MESH: Animals
Placental lactogen
Receptor
Peptide sequence
0303 health sciences
Crystallography
MESH: Crystallography
MESH: X-Ray Diffraction
Ligand (biochemistry)
Recombinant Proteins
MESH: Glycine
3. Good health
MESH: Surface Plasmon Resonance
MESH: Mutagenesis, Site-Directed
Protein Structure and Folding
Dimerization
hormones, hormone substitutes, and hormone antagonists
MESH: Placental Lactogen
endocrine system
MESH: Rats
Stereochemistry
Receptors, Prolactin
Molecular Sequence Data
Glycine
MESH: Prolactin
MESH: Sheep
Biology
03 medical and health sciences
Structure-Activity Relationship
MESH: Receptors, Prolactin
Structure–activity relationship
Animals
Humans
Amino Acid Sequence
Binding site
Molecular Biology
030304 developmental biology
Binding Sites
Sheep
MESH: Humans
MESH: Molecular Sequence Data
Cell Biology
Surface Plasmon Resonance
Placental Lactogen
Prolactin
Protein Structure, Tertiary
Rats
MESH: Binding Sites
MESH: Dimerization
Drug Design
Mutagenesis, Site-Directed
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 00219258 and 1083351X
- Database :
- OpenAIRE
- Journal :
- Journal of Biological Chemistry, Journal of Biological Chemistry, 2010, 285 (11), pp.8422-8433. ⟨10.1074/jbc.M109.089128⟩, Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2010, 285 (11), pp.8422-8433. ⟨10.1074/jbc.M109.089128⟩
- Accession number :
- edsair.doi.dedup.....f05eb2abee8c0ddefa3182cf55ca9ccb